Maduskuie, Jr.; Thomas P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Maduskuie, Jr.; Thomas P..The latest application filed is for "1h-pyrrolo[2,3-c]pyridin-7(6h)-ones and pyrazolo[3,4-c]pyridin-7(6h)-ones as inhibitors of bet proteins".

Company Profile

12.28.34

Maduskuie, Jr.; Thomas P. - Wilmington DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Heterocyclylamines as PI3K inhibitors Grant 11,433,071 - Li , et al. September 6, 2	2022-09-06
1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS App 20210300925 - Combs; Andrew P. ; et al.	2021-09-30
1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins Grant 11,059,821 - Combs , et al. July 13, 2	2021-07-13
Tricyclic Heterocycles As Bet Protein Inhibitors App 20210188872 - Combs; Andrew P. ; et al.	2021-06-24
Tricyclic heterocycles as BET protein inhibitors Grant 10,919,912 - Combs , et al. February 16, 2	2021-02-16
1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS App 20200377502 - Combs; Andrew P. ; et al.	2020-12-03
Heterocyclylamines As Pi3k Inhibitors App 20200323858 - Li; Yun-Long ; et al.	2020-10-15
1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins Grant 10,781,209 - Combs , et al. Sept	2020-09-22
Heterocyclylamines as PI3K inhibitors Grant 10,646,492 - Li , et al.	2020-05-12
Tricyclic Heterocycles As Bet Protein Inhibitors App 20200131195 - Combs; Andrew P. ; et al.	2020-04-30
1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS App 20200048251 - Combs; Andrew P. ; et al.	2020-02-13
1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins Grant 10,472,358 - Combs , et al. Nov	2019-11-12
Tricyclic heterocycles as BET protein inhibitors Grant 10,464,947 - Combs , et al. No	2019-11-05
Heterocyclylamines As Pi3k Inhibitors App 20190134040 - Li; Yun-Long ; et al.	2019-05-09
Bicyclic azaheterocyclobenzylamines as PI3K inhibitors Grant 10,259,818 - Combs , et al.	2019-04-16
Use Of Pyrazolopyrimidine Derivatives For The Treatment Of Pi3k-delta Related Disorders App 20190040067 - Li; Yun-Long ; et al.	2019-02-07
Bicyclic Azaheterocyclobenzylamines As Pi3k Inhibitors App 20190002470 - Combs; Andrew P. ; et al.	2019-01-03
Tricyclic Heterocycles As Bet Protein Inhibitors App 20180346481 - Combs; Andrew P. ; et al.	2018-12-06
1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS App 20180312506 - Combs; Andrew P. ; et al.	2018-11-01
Heterocyclylamines as PI3K inhibitors Grant 10,092,570 - Li , et al. October 9, 2	2018-10-09
1H-pyrrolo[2,3,c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins Grant 9,957,268 - Combs , et al. May 1, 2	2018-05-01
Bicyclic azaheterocyclobenzylamines as PI3K inhibitors Grant 9,944,646 - Combs , et al. April 17, 2	2018-04-17
Tricyclic heterocycles as BET protein inhibitors Grant 9,938,294 - Combs , et al. April 10, 2	2018-04-10
Heterocyclylamines As Pi3k Inhibitors App 20170340641 - Li; Yun-Long ; et al.	2017-11-30
N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors Grant 9,815,839 - Li , et al. November 14, 2	2017-11-14
Heterocyclylamines as PI3K inhibitors Grant 9,730,939 - Li , et al. August 15, 2	2017-08-15
Tricyclic Heterocycles As Bet Protein Inhibitors App 20170217985 - Combs; Andrew P. ; et al.	2017-08-03
Tricyclic Heterocycles As Bet Protein Inhibitors App 20170210754 - Combs; Andrew P. ; et al.	2017-07-27
N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines As Pi3k Inhibitors App 20170158696 - Li; Yun-Long ; et al.	2017-06-08
1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS App 20170158689 - Combs; Andrew P. ; et al.	2017-06-08
Tricyclic heterocycles as BET protein inhibitors Grant 9,624,241 - Combs , et al. April 18, 2	2017-04-18
1H-pyrrolo[2,3-c]pyridin-7(6H)-ones and pyrazolo[3,4-c]pyridin-7(6H)-ones as inhibitors of BET proteins Grant 9,540,368 - Combs , et al. January 10, 2	2017-01-10
Tricyclic heterocycles as BET protein inhibitors Grant 9,533,997 - Combs , et al. January 3, 2	2017-01-03
Bicyclic Azaheterocyclobenzylamines As Pi3k Inhibitors App 20160264580 - Combs; Andrew P. ; et al.	2016-09-15
Tricyclic Heterocycles As Bet Protein Inhibitors App 20160159817 - Combs; Andrew P. ; et al.	2016-06-09
Bicyclic azaheterocyclobenzylamines as PI3K inhibitors Grant 9,309,251 - Combs , et al. April 12, 2	2016-04-12
Tricyclic heterocycles as BET protein inhibitors Grant 9,290,514 - Combs , et al. March 22, 2	2016-03-22
Tricyclic Heterocycles As Bet Protein Inhibitors App 20160046650 - Combs; Andrew P. ; et al.	2016-02-18
Heterocyclylamines As Pi3k Inhibitors App 20160024117 - Li; Yun-Long ; et al.	2016-01-28
1H-PYRROLO[2,3-c]PYRIDIN-7(6H)-ONES AND PYRAZOLO[3,4-c]PYRIDIN-7(6H)-ONES AS INHIBITORS OF BET PROTEINS App 20150307493 - Combs; Andrew P. ; et al.	2015-10-29
N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors Grant 9,096,600 - Li , et al. August 4, 2	2015-08-04
Tricyclic Heterocycles As Bet Protein Inhibitors App 20150011540 - Combs; Andrew P. ; et al.	2015-01-08
Use Of Pyrazolopyrimidine Derivatives For The Treatment Of Pi3k-delta Related Disorders App 20140249132 - Li; Yun-Long ; et al.	2014-09-04
Heteroaryl Substituted Pyrrolo[2,3-B] Pyridines And Pyrrolo[2,3-B] Pyrimidines As Janus Kinase Inhibitors App 20140005210 - Rodgers; James D. ; et al.	2014-01-02
Bicyclic Azaheterocyclobenzylamines As Pi3k Inhibitors App 20130261101 - Combs; Andrew P. ; et al.	2013-10-03
HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS App 20130137681 - Rodgers; James D. ; et al.	2013-05-30
Heterocyclylamines As Pi3k Inhibitors App 20130059835 - Li; Yun-Long ; et al.	2013-03-07
N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines As Pi3k Inhibitors App 20120157430 - Li; Yun-Long ; et al.	2012-06-21
HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS App 20110224157 - Rodgers; James D. ; et al.	2011-09-15
HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS App 20110223210 - Rodgers; James D. ; et al.	2011-09-15
HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS App 20100022522 - Rodgers; James D. ; et al.	2010-01-28
Tetracyclic Inhibitors Of Janus Kinases App 20090215766 - Rodgers; James D. ; et al.	2009-08-27
HETEROARYL SUBSTITUTED PYRROLO[2,3-b]PYRIDINES AND PYRROLO[2,3-b]PYRIMIDINES AS JANUS KINASE INHIBITORS App 20090181959 - Rodgers; James D. ; et al.	2009-07-16
Cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-.alpha. Grant 6,984,648 - Lu , et al. January 10, 2	2006-01-10
Cyclic .beta.-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-.alpha. Grant 6,743,807 - Duan , et al. June 1, 2	2004-06-01
Lactam metalloprotease inhibitors Grant 6,610,731 - Duan , et al. August 26, 2	2003-08-26
.beta.-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-.alpha. Grant 6,495,565 - Duan , et al. December 17, 2	2002-12-17
Lactam metalloprotease inhibitors Grant 6,403,632 - Duan , et al. June 11, 2	2002-06-11
Lactam metalloprotease inhibitors Grant 6,057,336 - Duan , et al. May 2, 2	2000-05-02
Use of imidazoles for the treatment of atherosclerosis Grant 5,166,214 - Billheimer , et al. November 24, 1	1992-11-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.